Corrigendum to “Evaluation and Management of Skeletal Health in Celiac Disease: Position Statement”

In the article titled “Evaluation and Management of Skeletal Health in Celiac Disease: Position Statement” [1], there was an error regarding the FRAX® tool, which should be clarified as follows.

The article notes: “The WHO has developed an absolute fracture risk assessment tool (‘FRAX’) to estimate the 10-year fracture risk in all adults, which is based on the integration of femoral neck bone density, age and other important clinical risk factors [66].” However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2]. The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010. Treatment guidelines must undergo a formal process before they can be endorsed by the WHO.